Raymond James & Associates’s Redhill Biopharma RDHL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q2
Sell
-33
Closed -$243K 3973
2021
Q1
$243K Sell
33
-11
-25% -$81K ﹤0.01% 3462
2020
Q4
$357K Buy
44
+25
+132% +$203K ﹤0.01% 3002
2020
Q3
$189K Buy
+19
New +$189K ﹤0.01% 3211